Effectiveness of Clopidogrel Resinate in PCI(PRIDE)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1056 participants.
Also called NCT01349777
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 1,056 participants
- Registry
-
NCT01349777
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01349777. Randomized; no masking; primary purpose prevention. Start 2010-03-15 (actual); primary completion 2017-03-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness of Clopidogrel Resinate in PCI(PRIDE)
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Pregrel®
- Intervention (Drug)
- Plavix®
- Lead sponsor
- Seung-Jung Park
- Collaborator
- CardioVascular Research Foundation, Korea
Record details
- Record id
cardio:ct-nct01349777- Content hash
da87488f964568d29b4f9963cbcd3a3b547c8e69d057db64b93b47d98661d773